{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:18:24Z","timestamp":1783970304737,"version":"3.55.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Preclinical data indicates reciprocal activation of the complement system and the coagulation cascade. The magnitude of this interaction in patients with acute myocardial infarction is unknown. We aimed to determine associations between circulating markers of complement and coagulation activation in patients with acute ST-elevation myocardial infarction (STEMI), and explore a possible link to myocardial injury and left ventricular dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>We included 864 patients with STEMI. Blood was drawn at a median of 18 hours after percutaneous coronary intervention. Complement activation was assessed by the terminal complement complex (TCC), and coagulation activation by prothrombin fragment 1 + 2 (F1 + 2), D-dimer and endogenous thrombin potential (ETP). Myocardial injury was estimated by peak troponin T (TnT), and left ventricular function was quantified on echocardiography by left ventricular ejection fraction (LVEF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TCC was weakly correlated to F1 + 2 (r=0.086, p=0.012), D-dimer (r=0.176, p&amp;lt;0.001) and ETP (r=0.144, p&amp;lt;0.001). In multivariate binary logistic regression, there was no significant interaction between TCC and the coagulation markers on the risk of having high peak TnT or low LVEF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this STEMI cohort, complement activation as measured by TCC was weakly associated with markers of coagulation activation, but the measured markers had no combined relation with the risk of high peak TnT or low LVEF. These findings suggest that while simultaneous activation of complement and coagulation cannot be ruled out, combined high levels of TCC and coagulation markers do not mirror the extent of myocardial injury or dysfunction in STEMI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1613603","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T05:22:42Z","timestamp":1762233762000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Combined complement and coagulation activation in ST-elevation myocardial infarction: associations with myocardial injury and dysfunction"],"prefix":"10.3389","volume":"16","author":[{"given":"Karsten E.","family":"Kluge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrun","family":"Halvorsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir \u00d8.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte H.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingebj\u00f8rg","family":"Seljeflot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theis","family":"T\u00f8nnessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida G.","family":"Lunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragnhild","family":"Helseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system part I - molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.918775","article-title":"Coagulation and complement: Key innate defense participants in a seamless web","volume":"13","author":"Pryzdial","year":"2022","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00257","article-title":"Complement system part II: role in immunity","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615947","article-title":"A cell-based model of hemostasis","volume":"85","author":"Hoffman","year":"2001","journal-title":"Thromb Haemost"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture","volume":"114","author":"Bentzon","year":"2014","journal-title":"Circ Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00896-3","article-title":"Complement in ischaemia-reperfusion injury and transplantation","volume":"43","author":"Howard","year":"2021","journal-title":"Semin Immunopathol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00049","article-title":"Platelets and the complement cascade in atherosclerosis","volume":"6","author":"Patzelt","year":"2015","journal-title":"Front Physiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2010.535556","article-title":"Role of complement and perspectives for intervention in ischemia-reperfusion damage","volume":"44","author":"Banz","year":"2012","journal-title":"Ann Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bcp.2013.12.013","article-title":"Ischemia\/reperfusion injury: effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition","volume":"88","author":"Duehrkop","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1160\/TH17-02-0079","article-title":"Coagulation factor and protease pathways in thrombosis and cardiovascular disease","volume":"117","author":"Ten Cate","year":"2017","journal-title":"Thromb Haemost"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14161","article-title":"Pleiotropic effects of the hemostatic system","volume":"16","author":"Kremers","year":"2018","journal-title":"J Thromb Haemost"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2507","article-title":"Ischemia and reperfusion\u2013from mechanism to translation","volume":"17","author":"Eltzschig","year":"2011","journal-title":"Nat Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ahj.2021.09.007","article-title":"In vivo evidence of atherosclerotic plaque erosion and healing in patients with acute coronary syndrome using serial optical coherence tomography imaging","volume":"243","author":"Yin","year":"2022","journal-title":"Am Heart J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.tmrv.2019.08.004","article-title":"Complement and coagulation: cross talk through time","volume":"33","author":"Dzik","year":"2019","journal-title":"Transfus Med Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903678","article-title":"Molecular intercommunication between the complement and coagulation systems","volume":"185","author":"Amara","year":"2010","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018812","article-title":"Requirements for membrane attack complex formation and anaphylatoxins binding to collagen-activated platelets","volume":"6","author":"Martel","year":"2011","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2011.05.010","article-title":"Advances in assay of complement function and activation","volume":"63","author":"Harboe","year":"2011","journal-title":"Adv Drug Delivery Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"100228","DOI":"10.1016\/j.ahjo.2022.100228","article-title":"Complement activation in association with clinical outcomes in ST-elevation myocardial infarction","volume":"24","author":"Kluge","year":"2022","journal-title":"Am Heart J Plus"},{"key":"B19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12959-015-0061-1","article-title":"Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction","volume":"13","author":"Hansen","year":"2015","journal-title":"Thromb J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.08.023","article-title":"Circulating levels of the terminal complement complex are associated with hypercoagulability in patients with stable coronary artery disease","volume":"196","author":"Kluge","year":"2020","journal-title":"Thromb Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.rinim.2013.11.002","article-title":"IL-6 signalling in patients with acute ST-elevation myocardial infarction","volume":"4","author":"Ritschel","year":"2014","journal-title":"Results Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ejh.13171","article-title":"Anticoagulation in the cardiac patient: A concise review","volume":"102","author":"Larson","year":"2019","journal-title":"Eur J Haematol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02664","article-title":"Age and sex-associated changes of complement activity and complement levels in a healthy caucasian population","volume":"9","author":"Gaya da Costa","year":"2018","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp070","article-title":"C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction","volume":"30","author":"\u00d8rn","year":"2009","journal-title":"Eur Heart J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2004.01425.x","article-title":"C-reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion","volume":"34","author":"Nijmeijer","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"B28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ahj.2012.04.007","article-title":"Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial","volume":"164","author":"Martel","year":"2012","journal-title":"Am Heart J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2007.12.062","article-title":"Pexelizumab in ischemic heart disease: A systematic review and meta-analysis on 15,196 patients","volume":"136","author":"Testa","year":"2008","journal-title":"J Thorac Cardiovasc Surgery"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1177\/1076029618764847","article-title":"Markers of thrombin generation are associated with long-term clinical outcome in patients with ST-segment elevation myocardial infarction","volume":"24","author":"Hansen","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"B31","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0735-1097(97)00539-1","article-title":"Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries","volume":"31","author":"Granger","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160955","article-title":"D-dimer levels predict myocardial injury in ST-segment elevation myocardial infarction: A cardiac magnetic resonance imaging study","volume":"11","author":"Choi","year":"2016","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12959-021-00354-y","article-title":"D-dimer for risk stratification and antithrombotic treatment management in acute coronary syndrome patients: a systematic review and metanalysis","volume":"19","author":"Biccir\u00e8","year":"2021","journal-title":"Thromb J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23017","article-title":"C-reactive protein during and after myocardial infarction in relation to cardiac injury and left ventricular function at follow-up","volume":"41","author":"Vanhaverbeke","year":"2018","journal-title":"Clin Cardiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-011-0280-x","article-title":"Interactions between coagulation and complement\u2013their role in inflammation","volume":"34","author":"Oikonomopoulou","year":"2012","journal-title":"Semin Immunopathol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02035","article-title":"IL-6 receptor inhibition by tocilizumab attenuated expression of C5a receptor 1 and 2 in non-ST-elevation myocardial infarction","volume":"9","author":"Orrem","year":"2018","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.23.2527","article-title":"Thrombolytic therapy in acute myocardial infarction: comparison of procoagulant effects of streptokinase and alteplase regimens with focus on the kallikrein system and plasmin","volume":"98","author":"Hoffmeister","year":"1998","journal-title":"Circulation"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-9560-11-1","article-title":"Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy","volume":"11","author":"Solheim","year":"2013","journal-title":"Thromb J"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3324\/%x","article-title":"Effects of unfractionated and low molecular weight heparins on plasma levels of hemostatic factors in patients with acute coronary syndromes","volume":"86","author":"Vila","year":"2001","journal-title":"Haematologica"},{"key":"B40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.imlet.2018.06.006","article-title":"Complement activation in acute myocardial infarction: An early marker of inflammation and tissue injury","volume":"200","author":"Bavia","year":"2018","journal-title":"Immunol Lett"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1159\/000232428","article-title":"Effect of aspirin on the complement system in vitro","volume":"61","author":"H\u00e4nsch","year":"1980","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12777","article-title":"New insight into the effects of heparinoids on complement inhibition by C1-inhibitor","volume":"184","author":"Poppelaars","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.6.2666","article-title":"Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator","volume":"90","author":"Agostoni","year":"1994","journal-title":"Circulation"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(98)00126-1","article-title":"Influence of low- and high-dose aspirin treatment on thrombin generation in whole blood","volume":"92","author":"Wall\u00e9n","year":"1998","journal-title":"Thromb Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-200204000-00010","article-title":"Decrease in sensitivity of D-dimer for acute venous thromboembolism after starting anticoagulant therapy","volume":"13","author":"Couturaud","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00254","article-title":"Heparins: A shift of paradigm","volume":"6","author":"Hemker","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.09.024","article-title":"A test in context: D-dimer","volume":"70","author":"Weitz","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(92)90182-A","article-title":"Influence of heparin treatment on biochemical markers of an activation of the coagulation system","volume":"66","author":"Amelsberg","year":"1992","journal-title":"Thromb Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12026-011-8239-5","article-title":"Membrane attack by complement: the assembly and biology of terminal complement complexes","volume":"51","author":"Tegla","year":"2011","journal-title":"Immunol Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1613603\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T05:22:44Z","timestamp":1762233764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1613603\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2025.1613603"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1613603","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"article-number":"1613603"}}